GGrantIndex
Sort

40,608 grants matching prostate cancer

Harnessing digital health and implementation science to promote uptake of depression treatment in cancer settings: iCan DepCare

$669,731
Nathalie Moise · Columbia University Health Sciences · R01 · FY2025 · CA

Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring

$669,724
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2025 · CA

Long-term health consequences of birth by cesarean section

$669,651
Jorge Eduardo Chavarro · Harvard School Of Public Health · R01 · FY2019 · HD

Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

$669,636
· N01 · FY2008 · CA

Imaging Immune Modulation in Chimeric Antigen Receptor (CAR) T Cell Therapy

$669,635
Ronald G Blasberg · Sloan-Kettering Inst Can Research · R01 · FY2017 · CA

Variation in tumor-associated immune profiles and colorectal cancer outcomes

$669,492
Stephanie L. Schmit · Cleveland Clinic Lerner Com-Cwru · R01 · FY2022 · CA

Optimizing Treatment of Prostate Cancer in Men living with HIV

$669,481
Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Data Processing, Analysis and Modeling Unit

$669,457
Jeremy Goecks · Oregon Health & Science University · U2C · FY2022 · CA

Measuring Metabolic Activity in Prostate Cancer Bone Metastases Using Hyperpolarized 13C Pyruvate MRI for Improved Targeted Therapy Monitoring

$669,448
Daniel B Vigneron · University Of California, San Francisco · R01 · FY2021 · CA

Biomarkers of Hormone Therapy Response in a Multicenter Prostate Cancer Trial

$669,388
Amir Goldkorn · University Of Southern California · R01 · FY2016 · CA

International Consortium for the Genetics of Biliary Tract Cancers Cholangiocarcinoma Genome Wide Association Study

$669,307
Lewis R Roberts · Mayo Clinic Rochester · U01 · FY2025 · CA

Optimizing Treatment of Prostate Cancer in Men living with HIV

$669,206
Keith Magnus Sigel · Icahn School Of Medicine At Mount Sinai · R01 · FY2024 · CA

Improving Cancer Outcomes for African-Americans

$669,177
Patrick D Maguire · New Hanover Regional Medical Center · U56 · FY2006 · CA

Vault-CCL21 Nanocapsule for Lung Cancer

$669,156
Indresh K Srivastava · Protein Sciences Corporation · U44 · FY2014 · CA

Addressing challenges in colorectal cancer risk prediction

$669,119
Kerrie P Nelson · Boston University Medical Campus · R01 · FY2025 · CA

Dual kV/MV Imaging for Metal Artifact Reduction

$669,112
Rebecca Fahrig · Stanford University · R01 · FY2011 · CA

Theranostic gold nanoparticles for imaged-guided radical prostatectomy and PDT ablation

$668,936
James Peter Basilion · Case Western Reserve University · R01 · FY2016 · EB

Evaluation of novel treatments in biochemically recurrent prostate

$668,924
Ravi Madan · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA

Quantitative Image Informatics for Cancer Research (QIICR)

$668,889
Ron Kikinis · Brigham And Women'S Hospital · U24 · FY2016 · CA

Quantitative Image Informatics for Cancer Research (QIICR)

$668,865
Ron Kikinis · Brigham And Women'S Hospital · U24 · FY2017 · CA

Maryland Prostate Cancer Case-Control Study

$668,844
Stefan Ambs · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA

A Phase 1 Study to Evaluate Chimeric Antigen Receptor (CAR) T cells Targeting TAG72 in Patients with Recurrent Epithelial Ovarian Cancer

$668,834
Lorna Rodriguez-Rodriguez · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA

Signaling Mechanisms of EphrinB1 in Cell Adhesion, Migration and Invasion

$668,635
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Mechanisms of Cross-talk Between EphrinB and Alternate Signaling Pathways

$668,635
Ira Daar · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy

$668,565
Kosj Yamoah · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2025 · CA